Medical & affiliate disclosure: CTX Stat provides educational laboratory information and is not a substitute for professional medical advice, diagnosis, or treatment. CTX Stat may receive compensation from some outbound provider links when an affiliate program is active; provider comparisons and rankings are based on consumer fit, effective cost, access, policies, and reputation—not commission.
Quick take
- The most common STI blood tests screen for HIV, syphilis, hepatitis B, and hepatitis C. Herpes blood testing is sometimes used, but it is not a routine screening test for everyone.
- Blood tests do not cover every STI. Chlamydia, gonorrhea, and trichomoniasis are usually tested with urine or swabs from the vagina, cervix, penis/urethra, rectum, or throat, depending on exposure sites.
- Timing matters. A negative blood test soon after exposure may not be final because antibody, antigen, or viral RNA levels may not yet be detectable.
- Positive screening results often need confirmation or interpretation. Syphilis testing requires more than one type of blood test, HIV testing follows a laboratory algorithm, and hepatitis C antibody testing is followed by RNA testing when reactive.
- A good STI screen is risk-based, not just “the biggest panel.” The right test set depends on symptoms, pregnancy status, anatomy, sexual practices, new or multiple partners, known exposure, PrEP use, vaccination history, and prior infections.
What STI blood tests can—and cannot—detect
STI blood tests look for evidence of infection in the bloodstream. Depending on the infection, the lab may measure antibodies made by your immune system, antigens from the organism, or viral genetic material such as RNA. In everyday screening, the blood-based STI tests people encounter most often are HIV testing, syphilis serology, hepatitis B testing, hepatitis C testing, and sometimes herpes simplex virus antibody testing.
That does not mean a blood draw is a complete STI screen. Several common sexually transmitted infections live primarily at a specific body site and are best detected by testing a sample from that site. For example, if someone had oral sex and is concerned about throat gonorrhea, a urine test and a blood test may both miss the throat infection; a throat swab is the more relevant sample. The CDC’s patient guidance notes that STI testing may require blood, urine, or swabs from the vagina, throat, or rectum, depending on what needs to be checked (CDC: Getting Tested for STIs).
The most practical way to think about STI blood tests is this: they are essential for certain infections, but they are only one part of screening. A complete screen is built from the right combination of blood, urine, and swab tests based on exposure and risk.
Common STI blood tests
| Infection | Common blood test | What it looks for | Important interpretation points |
|---|---|---|---|
| HIV | 4th-generation HIV antigen/antibody test; HIV-1 RNA NAT in selected situations | HIV antibodies, p24 antigen, or HIV RNA | Lab-based antigen/antibody testing is commonly used for screening. RNA testing can detect infection earlier and may be used when acute HIV is suspected. |
| Syphilis | RPR or VDRL plus a treponemal test such as EIA, CIA, TP-PA, or another treponemal assay | Antibodies associated with syphilis infection | Diagnosis requires both nontreponemal and treponemal information; one test alone can mislead. |
| Hepatitis B | HBsAg, anti-HBs, and total anti-HBc | Current infection, immunity, and past exposure patterns | The CDC recommends a three-test screening panel for adults who have never been screened. |
| Hepatitis C | HCV antibody with reflex HCV RNA if reactive | Past exposure first; current infection if RNA is detected | A reactive antibody test does not by itself prove current infection; RNA testing answers whether the virus is present now. |
| Herpes simplex virus type 1 or type 2 | Type-specific HSV-1/HSV-2 IgG antibody | Past immune response to HSV-1 or HSV-2 | Not routinely recommended for everyone without symptoms because false positives can occur, especially for low-positive HSV-2 results. |
HIV blood tests
HIV testing is one of the most important blood-based STI screens. Most clinical laboratories use an antigen/antibody test, often called a 4th-generation HIV test. This test looks for HIV antibodies and the p24 antigen, a viral protein that can appear before antibodies are fully developed. The CDC describes three major types of HIV tests: nucleic acid tests, antigen/antibody tests, and antibody tests (CDC: Clinical Testing Guidance for HIV).
For routine screening, a lab-based antigen/antibody test from a vein is commonly preferred because it detects infection earlier than antibody-only tests. If someone has symptoms of acute HIV—such as fever, rash, sore throat, swollen glands, or flu-like illness after a high-risk exposure—a clinician may consider HIV RNA testing because nucleic acid testing can detect HIV earlier than other test types.
According to CDC patient guidance, a nucleic acid test can usually detect HIV 10 to 33 days after exposure, a lab antigen/antibody test using blood from a vein can usually detect HIV 18 to 45 days after exposure, and antibody tests generally have a longer window period (CDC: Getting Tested for HIV). A negative result before the end of the relevant window period may need repeat testing.
A reactive HIV screening result should not be interpreted in isolation. Laboratories follow a recommended sequence to confirm infection and distinguish HIV-1 from HIV-2 when needed. If a home or community rapid test is positive, follow-up laboratory testing is necessary.
Syphilis blood tests
Syphilis is primarily diagnosed with blood tests, but it is not a one-line result. The CDC states that a presumptive syphilis diagnosis requires two types of serologic tests: a nontreponemal test, such as RPR or VDRL, and a treponemal test, such as TP-PA, EIA, CIA, immunoblot, or another treponemal assay (CDC: Syphilis Treatment Guidelines).
Nontreponemal tests such as RPR and VDRL are often reported as a titer, such as 1:4, 1:8, or 1:32. The titer helps clinicians assess disease activity and monitor response after treatment, but it is not interpreted like a simple positive-or-negative screen. Treponemal tests are more specific to syphilis-related antibodies, but they often remain reactive for life even after successful treatment. That is why a person with a past treated infection may still have a positive treponemal result.
Many laboratories now use a “reverse sequence” algorithm, where an automated treponemal immunoassay is run first and a quantitative RPR or VDRL is added if the first test is reactive. If the treponemal test is positive but the nontreponemal test is negative, the lab or clinician may use a second treponemal test to help determine whether the pattern reflects past treated syphilis, untreated infection, very early infection, or a false-positive screen. CDC’s 2024 laboratory recommendations emphasize using treponemal and nontreponemal tests in combination when the initial test is reactive (CDC Laboratory Recommendations for Syphilis Testing, United States, 2024).
Syphilis screening is especially important during pregnancy and for people at increased risk. CDC screening recommendations include syphilis testing for pregnant people early in pregnancy and at later points when risk or local law indicates, and at least annual testing for sexually active men who have sex with men, with more frequent testing for some higher-risk situations (CDC: STI Screening Recommendations).
Hepatitis B blood tests
Hepatitis B can be sexually transmitted, but it is also spread through blood exposure and from parent to baby during birth. It is vaccine-preventable, and blood testing can show whether someone has current infection, past infection, or immunity from vaccination.
The CDC’s adult hepatitis B screening guidance recommends a “triple panel” for adults who have never been screened: hepatitis B surface antigen (HBsAg), antibody to hepatitis B surface antigen (anti-HBs), and total antibody to hepatitis B core antigen (total anti-HBc) (CDC: Clinical Testing and Diagnosis for Hepatitis B). These three markers answer different questions:
- HBsAg suggests current hepatitis B infection, which may be acute or chronic depending on duration and other findings.
- Anti-HBs can indicate immunity, often from vaccination or recovery after infection.
- Total anti-HBc indicates previous or current natural infection; it is not produced by vaccination alone.
Because hepatitis B result patterns can be confusing, it is common for clinicians to interpret the three markers together rather than focusing on a single positive or negative line. People who are not immune may be offered vaccination, and people with evidence of current infection may need additional evaluation, counseling, and follow-up liver-related testing.
Hepatitis C blood tests
Hepatitis C is less efficiently transmitted through sex than some other STIs, but sexual transmission can occur, and screening is recommended broadly. The CDC recommends hepatitis C screening for all adults age 18 and older at least once, and for every pregnancy, except in settings where prevalence is extremely low (CDC: Testing for Hepatitis C).
Hepatitis C testing usually begins with an HCV antibody test. A nonreactive antibody result generally means there is no evidence of prior exposure, unless the exposure was recent or the person has impaired antibody response. A reactive antibody result means the immune system has seen hepatitis C at some point, but it does not prove current infection. Current infection is determined with a nucleic acid test for HCV RNA. CDC clinical guidance recommends initiating testing with an HCV antibody test and automatically performing HCV RNA testing when the antibody is reactive (CDC: Clinical Screening and Diagnosis for Hepatitis C).
This “reflex RNA” approach is important because it reduces the chance that a person receives an incomplete answer. If you order hepatitis C testing directly, check whether the service includes reflex RNA confirmation after a reactive antibody test or whether you would have to pay for and arrange the RNA test separately.
Herpes blood tests: useful in selected cases, not routine for everyone
Herpes blood testing is one of the most misunderstood parts of STI screening. A type-specific HSV IgG blood test can show whether a person has antibodies to HSV-1 or HSV-2. However, it usually cannot tell where the infection is located, when it was acquired, or whether a current sore is caused by herpes. If a person has an active lesion, direct testing from the lesion—typically PCR or NAAT when available—is usually more clinically useful than a blood antibody test.
CDC guidance says type-specific HSV-2 serologic testing can be useful in certain situations, such as recurrent or atypical genital symptoms with negative lesion testing, a clinical diagnosis without laboratory confirmation, or when a patient’s partner has genital herpes. The same guidance warns that the commonly used HSV-2 EIA can be falsely positive at low index values and that confirmatory testing should be considered when results are in the low-positive range (CDC: Genital Herpes Treatment Guidelines).
The FDA has also reminded clinicians and laboratories about the potential for false reactive HSV-2 serologic results, particularly when testing people with low likelihood of infection or when results are near the assay cutoff (FDA: HSV-2 Serologic Test Safety Communication). For that reason, “complete STI panels” that automatically include herpes blood tests may create anxiety without improving care for people who have no symptoms or specific indication for testing.
STIs that usually need urine or swab tests instead
Some of the most common STIs are not diagnosed with blood tests in routine screening. Chlamydia and gonorrhea are usually detected with nucleic acid amplification tests, often called NAATs. Samples may be urine, a vaginal swab, a cervical swab, a urethral/penile swab, a rectal swab, or a throat swab. The correct sample depends on the sites of sexual contact.
Trichomoniasis is also usually tested from a genital sample or urine, depending on anatomy and lab method. HPV is not part of a standard blood STI panel; cervical HPV testing is performed from a cervical sample in specific age groups and screening situations. Genital warts are usually diagnosed visually rather than through a blood test.
Why exposure site matters
If exposure occurred at the throat or rectum, a urine-only test can miss an infection at those sites. A person can have rectal or throat gonorrhea or chlamydia without urinary symptoms. When asking for STI screening, it is reasonable to tell the clinician or ordering service which body sites may have been exposed so the right swabs are included.
Timing and window periods
A window period is the time between an exposure and the point when a test is likely to detect an infection. Testing too early can produce a negative result even when infection is present. Window periods vary by organism and test method.
| Test | Why early testing can miss it | Practical next step after recent exposure |
|---|---|---|
| HIV antigen/antibody | Antigen and antibodies may not yet be detectable. | Ask whether repeat testing is needed after the window period; consider urgent care for possible PEP if exposure was within 72 hours. |
| HIV RNA NAT | Detects earlier than other HIV tests, but not immediately after exposure. | Used when acute HIV is suspected or when recommended by a clinician. |
| Syphilis serology | Antibodies may not be present in very early infection. | If exposure or symptoms are concerning, repeat testing and clinical evaluation may be needed. |
| Hepatitis C antibody | Antibody can take time to develop after exposure. | HCV RNA testing may be used when recent exposure is suspected. |
| HSV IgG | Antibodies may take weeks to months to develop. | For active sores, lesion testing is usually more useful than waiting for blood antibodies. |
Timing is also why symptoms should not be ignored just because a recent screening panel was negative. Painful sores, discharge, pelvic or testicular pain, fever after a high-risk exposure, rash on the palms or soles, or symptoms during pregnancy should prompt clinical evaluation rather than waiting for a routine screening interval.
How to interpret common STI blood test results
Negative does not always mean “no infection from a recent exposure”
A negative result is most reassuring when the right test was used, the right sample was collected, and enough time has passed since the last possible exposure. If the test was performed during the window period, repeat testing may be needed. If the test did not match the exposure site, additional urine or swab testing may be needed.
Reactive or positive results may need confirmation
HIV, syphilis, and hepatitis C testing commonly involve confirmatory or reflex steps. A reactive HIV screen is followed by additional testing. A syphilis result is interpreted by combining treponemal and nontreponemal tests, along with history and symptoms. A reactive hepatitis C antibody test should be followed by HCV RNA testing to determine whether infection is current.
Past infection and current infection are not the same
Some blood tests remain positive after an infection has resolved or been treated. Treponemal syphilis tests can stay reactive long after treatment. Hepatitis C antibody can remain reactive even after spontaneous clearance or successful treatment. HSV IgG indicates prior infection with that virus type, not necessarily a new infection or the cause of a current symptom.
Numbers matter for some tests
Syphilis RPR or VDRL titers are used to monitor treatment response. HSV-2 IgG index values may affect how likely a low-positive result is to be true. Hepatitis B panels depend on patterns across three markers. When possible, review the full lab report rather than relying on a portal summary that simply says “positive” or “abnormal.”
Who should consider STI blood testing?
Screening recommendations depend on age, pregnancy status, sexual practices, and risk factors. CDC recommendations include opt-out HIV screening for people ages 13 to 64 in health care settings and HIV testing for people seeking STI evaluation. The USPSTF recommends HIV screening for adolescents and adults ages 15 to 65, younger and older people at increased risk, and all pregnant persons (USPSTF: HIV Screening Recommendation).
Blood testing is particularly important if you are pregnant or planning pregnancy, have a new partner, have multiple partners, have a partner with an STI, are a man who has sex with men, use injection drugs, are starting or using HIV PrEP, have had a recent STI, have symptoms compatible with syphilis or acute HIV, or have never been screened for hepatitis B or C. People with known exposure should ask specifically which tests are appropriate now and which should be repeated later.
How to prepare for STI blood testing
Most STI blood tests do not require fasting. You can usually eat, drink water, and take routine medications unless your clinician gives different instructions for other labs ordered at the same time. Bring a list of medications, vaccines, prior STI diagnoses, and approximate dates of possible exposures if available.
Before the test, clarify what is included. A “full panel” may mean different things across clinics and direct-to-consumer services. Ask whether the order includes HIV 4th-generation testing, syphilis testing with confirmatory/reflex steps, hepatitis B triple-panel screening, hepatitis C antibody with reflex RNA, and site-specific swabs for chlamydia and gonorrhea if relevant. Also ask how positive results are communicated, whether treatment is available, and whether partner services are offered.
If privacy is a concern, ask how results are delivered, whether insurance will be billed, and whether an explanation of benefits may be sent to the policyholder. Public health clinics, Title X clinics, and community sexual health clinics may offer confidential or low-cost testing options, though rules vary by state and clinic.
Cost and ordering considerations
STI testing costs vary widely by setting. Planned Parenthood’s national patient information states that STD testing may cost anywhere from $0 to $250 depending on the tests needed, symptoms, insurance, income, and location, and that some health centers offer free or low-cost testing based on income (Planned Parenthood: Where to Get Tested). Local health departments and community clinics may also offer low-cost HIV, syphilis, hepatitis, and STI testing.
If you order testing through an online lab marketplace or direct-access service, compare the total price, not just the advertised lab price. The effective cost may include the lab test, clinician authorization fee, draw fee, shipping fee for home collection, reflex confirmation charges, and any follow-up visit needed for treatment. For hepatitis C, for example, an antibody-only test may look cheaper but may leave you paying separately for RNA confirmation if the antibody is reactive. For syphilis, a low-cost single test may not provide the full confirmatory pattern needed for interpretation.
Insurance coverage depends on the plan, the reason for testing, network status, and coding. Preventive screening may be covered in many situations, but diagnostic testing for symptoms or exposure can be billed differently. If avoiding insurance for privacy reasons, ask for the self-pay total before collection.
What to do after results come back
- Save the complete report. The exact test name, result, reference range, index value, or titer may matter.
- Ask whether the result is final. Some screens require reflex or confirmatory testing.
- Avoid assumptions about timing. A positive antibody result may reflect an older infection, while a negative early test may need repeating.
- Get treatment promptly when indicated. Many STIs are treatable, and early treatment lowers the risk of complications and transmission.
- Ask about partner notification. Partners may need testing, treatment, or preventive medication.
- Plan retesting. Some infections require test-of-cure or repeat screening at defined intervals, especially during pregnancy, after treatment, or with ongoing risk.
FAQs about STI blood tests
Can one blood test check for all STIs?
No. Blood tests are commonly used for HIV, syphilis, hepatitis B, hepatitis C, and sometimes herpes. Chlamydia, gonorrhea, trichomoniasis, and HPV generally require other sample types or clinical evaluation.
Which STI blood tests should be in a routine panel?
A common baseline panel includes HIV and syphilis blood tests, with hepatitis B and hepatitis C depending on prior screening, vaccination, pregnancy status, and risk factors. Many people also need chlamydia and gonorrhea NAAT testing from urine or swabs. Herpes blood testing should be selective rather than automatic for everyone.
Is a finger-prick blood test as accurate as a venous blood draw?
It depends on the test. Some rapid HIV tests use finger-stick blood and provide results quickly, but lab-based venous antigen/antibody testing generally has a shorter window period than many rapid antibody-only tests. Home collection tests can be useful when performed through a qualified lab, but you should review what specimen is collected and how reactive results are confirmed.
Why was my syphilis test positive if I was treated years ago?
Treponemal syphilis tests can remain positive for many years, sometimes for life, after treatment. Clinicians often use the RPR or VDRL titer, prior records, symptoms, and exposure history to determine whether the result suggests past treated infection, reinfection, or untreated infection.
Should I get herpes blood testing if I have no symptoms?
Usually not as a routine screen. Herpes blood tests can produce false-positive HSV-2 results, especially at low index values, and they do not show where infection is located. Testing may be reasonable in selected situations, such as a partner with genital herpes or recurrent symptoms with negative lesion tests.
How soon after sex should I get STI blood tests?
If you had a known high-risk exposure, seek care as soon as possible because time-sensitive prevention may be available, including HIV post-exposure prophylaxis within 72 hours in appropriate cases. For screening accuracy, timing varies by infection and test type. You may need initial testing now and repeat testing later after the window period.
Do STI blood tests require fasting?
Most STI blood tests do not require fasting. If other labs are ordered at the same visit, follow the instructions for those tests.
What if my STI blood tests are negative but I still have symptoms?
Do not assume blood testing ruled out every STI or non-STI condition. Symptoms such as discharge, sores, pelvic pain, testicular pain, rectal pain, throat symptoms after oral exposure, or rash may require an exam, swabs, urine tests, pregnancy testing, or evaluation for noninfectious causes.
Sources
- CDC — Getting Tested for STIs
- CDC — STI Screening Recommendations
- CDC — Getting Tested for HIV
- CDC — Syphilis Treatment Guidelines
- CDC MMWR — Laboratory Recommendations for Syphilis Testing, United States, 2024
- CDC — Clinical Testing and Diagnosis for Hepatitis B
- CDC — Clinical Screening and Diagnosis for Hepatitis C
- CDC — Genital Herpes Treatment Guidelines
- FDA — HSV-2 Serologic Test False Reactive Results
- USPSTF — HIV Infection Screening Recommendation
